In 2007, BradyKnows Medical (Brady, 贝迪诺恩) was founded in Beijing China by a group of medical device engineers, physicians, quality, and regulatory experts. These people were gathered by the commitment of introducing international life-improving and innovative medical devices to patients in China.
By 2021, BradyKnows has established 6 subsidiaries in China and US including Beijing, Shanghai, Hainan, Zaozhuang, Seattle, and California. Together, we offer One-Stop China Market Entry service including in-country legal representative, regulatory intelligence, and strategy, NMPA registration, CRO, testing, post-market surveillance and quality assurance, and translation.
By 2022, BradyKnows has served 300+ global medical device manufacturers. From 2017 to 2022, BradyKnows achieved 1,500+ China approvals and 6,000+ go-to-market strategies for our clients. Our in-house CRO team was awarded as the TOP 10 CROs in APAC in 2022.